Chiral technology in the drug production (go back »)

Chiral technology, the process of synthesizing or isolating chiral molecules and their single enantiomers, has become big business for a legion of catalyst developers and custom chemical manufacturers. A few of new drugs are single enantiomers, meaning two mirror-image isomers. Enantiomers are the molecules with pair of mirror image isomers. As drugs, single enantiomers often exhibit greater potency and cause fewer side effects than do more conventional drug molecules, which may be chiral but are often equal-parts mixtures of both enantiomers.

Global revenues from chiral technology will soar from $6.63 billion in 2000 to $16.03 billion in 2007, growing at a compound annual rate of 13.4% during that period.

Approximately 80% of all products currently in development for the pharmaceutical industry are based on chiral building blocks, according to Karlheinz Drauz, vice president for technology and R&D management in the fine chemicals business unit of Degussa AG in Hanau-Wolfgang, Germany. Many single-enantiomer chiral drugs have recently hit the market. Among the more successful ones are AstraZeneca's stomach acid remedy Nexium, GlaxoSmithKline's anti-anxiety agent Paxil, and Merck's asthma drug Singulair.

Bharatbook.com included a new report “Understanding Chiral Technologies” which analyzes the technology involved in the chiral processes, cost of the technology, worldwide sales, the different chiral models, major players in the industry, and the basics of the chiral industry. Market overview, market statistics, information for end-users, and much more is included in this report.

About Bharatbook.com:

Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.

For further information kindly visit: http://www.bharatbook.com/detail.asp?id=79481

In Health